Results 151 to 160 of about 120,548,321 (260)

European Guidelines on Multidisciplinary Management of Obstructed Defecation Syndrome—ESCP, UEG, ESGAR, EAGEN, ESGENA, ESNM and ESPCG

United European Gastroenterology Journal, Volume 14, Issue 9, November 2026.
ABSTRACT Introduction The goal of this project was to develop a joint European clinical practice guideline for the diagnosis and treatment of obstructed defecation syndrome (ODS), based on the best available evidence. These guidelines are intended to support all healthcare professionals involved in the care of patients with ODS, such as general ...
Gaetano Gallo, Marta Goglia, Jos Kleijnen, Doron Boltin, Cäcilia Sophie Reiner, Marco De Bastiani, Pierluigi Fracasso, Gregory Thomas, Ingrid Han‐Geurts, Heinrich Henriette, Katarina Karlović, Yasuko Maeda, Daniel Pohl, Mostafa Shalaby, Emre Sivrikoz, Jan Tack, Anastasia Tsalouka, Marcin Włodarczyk, Agnese Dezi, Arcangelo Picciariello   +19 more
wiley   +1 more source

Recovery from Abobotulinum Toxin A-Induced Paralysis Following Ozone Injection in a Split-Body Rabbit Model. [PDF]

Toxins (Basel)
Tuna A, Botsalı A, Şen M, Aksoy OA, Öztürk ÖB, Çalışkan E.   +5 more
europepmc   +1 more source

Characterisation of botulinum toxins type C, D, E, and F by matrix-assisted laser desorption ionisation and electrospray mass spectrometry

, 2004
In a follow-up of the earlier characterisation of botulinum toxins type A and B (BTxA and BTxB) by mass spectrometry (MS), types C, D, E, and F (BTxC, BTxD, BTxE, BTxF) were now investigated.
Baar, B.L.M. van, Jong, A.L. de, Hulst, A.G., Wils, E.R.J.   +3 more
core  

Health‐related quality of life and patient‐reported outcome measures in economic evaluation of urological technologies: challenges and opportunities

BJU International, Volume 138, Issue 5, Page 750-758, November 2026.
Objective To examine the role of health‐related quality of life (HRQoL) assessments and patient‐reported outcome measures (PROMs) in the economic evaluation of urological interventions, highlighting methodological challenges, and identifying areas for future development.
Mohammed El Bahnasawi, Charlotte Moss, Netty Kinsella, Kathie Alexina Wong, Mieke Van Hemelrijck   +4 more
wiley   +1 more source

Temporal Scientific Signals Associated with Regulatory Milestones in Anatomically Targeted Therapeutics: Evidence from Botulinum Toxin Research. [PDF]

Toxins (Basel)
Lin Y, Choi Y, Liu X, Jeon HD, Park HJ.
europepmc   +1 more source

Evaluation of a Multipolar MEMS Based Low‐Power Radiofrequency Device for Pain‐Free Facial Rejuvenation: A Prospective Clinical Study

Journal of Cosmetic Dermatology, Volume 25, Issue 11, November 2026.
ABSTRACT Background Noninvasive radiofrequency (RF) therapy has emerged as a prominent approach for facial rejuvenation due to its ability to stimulate collagen remodeling without epidermal ablation. However, conventional RF systems often rely on high thermal output, posing risks of heat‐induced dermal damage. Objective This study aimed to evaluate the
Rongwei Mao, Shengshuo Yan, Aditi A. Sharma, Tony Shum, Yang Zhang   +4 more
wiley   +1 more source

Monitoring of <i>Clostridium botulinum</i> in Poultry and Cattle Manure During Spreading Operations. [PDF]

Toxins (Basel)
Souillard R, Rouxel S, Dorenlor V, Kuntz G, Mahé F, Poezevara T, Eono F, Avouac A, Kerphérique S, Jambou L, Cailton E, Gouet M, Solanas S, Balaine L, Huneau-Salaün A, Chemaly M, Le Bouquin S, Hartmann A, Le Maréchal C.   +18 more
europepmc   +1 more source

Neutralizing antibodies to botulinum neurotoxin type A in aesthetic medicine: five case reports

, 2013
Sebastian Torres,1 Mark Hamilton,2 Elena Sanches,4 Polina Starovatova,3 Elena Gubanova,3 Tatiana Reshetnikova51Di Stefano Velona Clinic, Catania, Italy; 2Hamilton Face Clinic, Dublin, Ireland; 3Preventive Medicine Clinic "Vallex M", Moscow ...
Sanches E, Starovatova P, Reshetnikova T, Gubanova E, Torres S, Hamilton M   +5 more
core  

Clinical and Functional Effectiveness of Botulinum Toxin in Temporomandibular Disorders: A Systematic Review of Randomized Controlled Trials. [PDF]

Toxins (Basel)
Ronconi G, Calciano R, Cutaia A, Cioffi R, Farag EA, Sanfilippo A, Ferrillo M, de Sire A, Ferrara PE.   +8 more
europepmc   +1 more source

Botulinum Toxin Therapy for Diseases in the Oral and Maxillofacial Regions: Current Evidence and Future Perspectives. [PDF]

Toxins (Basel)
Yoshida K.
europepmc   +1 more source